DWIBS across three b-values provides an alternative, contrast-free method for breast lesion characterization with high reproducibility and merits prospective validation within full DCE-MRI protocols in larger multicenter studies before clinical adoption.
Abstract
Rationale
AND
Objectives
To evaluate the diagnostic accuracy and inter-observer reliability of qualitative signal intensity (SI) changes across three b-values in diffusion-weighted imaging with background suppression (DWIBS) for differentiating benign from malignant breast lesions.
Materials And Methods
This prospective diagnostic accuracy study enrolled 113 consecutive female patients (mean age 44.7 ± 12.1 years) with sono-mammographically suspicious lesions who underwent breast MRI including T2-weighted imaging and DWIBS at b-values of 800, 1000, and 1500 s/mm². Three expert breast-imaging radiologists independently assessed T2WI, SI behavior across b-values, and assigned a final ACR BI-RADS MRI category. Diagnostic performance was computed using the histopathological examination as the reference standard. Chi-square/Fisher exact tests evaluated the association between SI pattern on DWIBS and malignant outcome. Inter-observer agreement was assessed with Fleiss' kappa (SI classification).
Results
Of 113 lesions, 64 (56.6%) were malignant and 49 (43.4%) were benign. SI changes from b = 800 to 1500s/mm² yielded sensitivity of 85.7-90.5%, specificity of 100%, and accuracy of 92.0-94.7% between reader 1 and 2 considering the increased SI as the optimal cutoff for predicting malignancy. While reader 3 recorded a stable/isointense SI as the best cutoff for predicting malignancy with sensitivity of 100%, specificity of 87.5% and accuracy of 94.7%. Inter-observer agreement was almost perfect for SI changes (κ = 0.856, p < 0.001).
Conclusion
DWIBS across three b-values provides an alternative, contrast-free method for breast lesion characterization with high reproducibility. DWIBS merits prospective validation within full DCE-MRI protocols in larger multicenter studies before clinical adoption.
OBJECTIVE
To determine whether intravoxel incoherent motion (IVIM) diffusion-weighted imaging (DWI) parameters combined with dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) time-signal intensity curve (TIC) can help distinguish benign from malignant BI-RADS 4 breast lesions.
MATERIALS AND METHODS
This...
Chao Huang, Zhi-Feng Wang, Wen-Ting Zhang et al.· European Journal of Radiolog...· 0 citations
Abbreviated breast MRI is a feasible and time-efficient approach with consistent diagnostic performance across readers for evaluating suspicious MC, and MIP-only evaluation, does not appear to provide sufficient diagnostic reliability.
P. Pöschke, E. Wenkel, C. Schulmeyer et al.· Anticancer Research· 0 citations
BACKGROUND
The associations of tumor location and reader experience with Vesical Imaging-Reporting and Data System (VI-RADS) performance remain unclear.
PURPOSE
To evaluate the associations of tumor location and reader experience with VI-RADS performance in detecting muscle-invasive bladder cancer (MIBC).
STUDY TYP...
Xiang-Yu Wang, Feng Sun, Jing-Jun Hu et al.· Journal of Magnetic Resonanc...· 1 citation
While conventional MRI provides excellent anatomical delineation of brain tumors, it remains fundamentally limited in predicting cellularity or histological grade preoperatively. Apparent diffusion coefficient (ADC) values, derived from diffusion-weighted imaging (DWI), quantify microscopic water mobility, serving as a...
M. Monis, Atul Kumar, Sayeedul Hasan Arif et al.· The Egyptian Journal of Radi...· 0 citations
PURPOSE
To systematically evaluate the impact of MRI software updates on apparent diffusion coefficient (ADC) values, assess potential left-right asymmetry in bilateral breast ADC values, and explore standardization techniques to enhance diagnostic reliability in lesion classification.
METHODS
A total of 420 patients...
H. Okuma, M. Könönen, Amro Masarwah et al.· Clinical imaging· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.